Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib.
Weiss J, Kavanagh B, Deal A, Villaruz L, Stevenson J, Camidge R, Borghaei H, West J, Kirpalani P, Morris D, Lee C, Pecot CV, Zagar T, Stinchcombe T, Pennell N.
Weiss J, et al. Among authors: camidge r.
Cancer Treat Res Commun. 2019;19:100126. doi: 10.1016/j.ctarc.2019.100126. Epub 2019 Feb 26.
Cancer Treat Res Commun. 2019.
PMID: 30852467
Clinical Trial.